| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Respiration | 36 | 2024 | 262 | 10.290 |
Why?
|
| Respiratory Center | 25 | 2022 | 53 | 6.290 |
Why?
|
| Nerve Net | 34 | 2021 | 366 | 5.690 |
Why?
|
| Neurons | 40 | 2023 | 1546 | 4.940 |
Why?
|
| Respiratory Insufficiency | 8 | 2024 | 150 | 4.850 |
Why?
|
| Respiratory Mechanics | 19 | 2014 | 102 | 4.100 |
Why?
|
| Medulla Oblongata | 15 | 2024 | 89 | 4.090 |
Why?
|
| Periodicity | 17 | 2019 | 119 | 3.880 |
Why?
|
| Brain Stem | 17 | 2021 | 165 | 3.150 |
Why?
|
| Rett Syndrome | 8 | 2022 | 19 | 2.980 |
Why?
|
| Analgesics, Opioid | 6 | 2024 | 411 | 2.800 |
Why?
|
| Biological Clocks | 14 | 2011 | 74 | 2.610 |
Why?
|
| Synaptic Transmission | 15 | 2022 | 222 | 2.400 |
Why?
|
| Models, Neurological | 9 | 2019 | 405 | 2.070 |
Why?
|
| Hypoxia | 16 | 2024 | 641 | 2.010 |
Why?
|
| Action Potentials | 22 | 2016 | 573 | 1.910 |
Why?
|
| Inhalation | 5 | 2021 | 31 | 1.880 |
Why?
|
| Mice | 65 | 2024 | 11339 | 1.870 |
Why?
|
| Animals | 86 | 2024 | 26567 | 1.850 |
Why?
|
| Autonomic Nervous System Diseases | 4 | 2023 | 19 | 1.810 |
Why?
|
| Arousal | 6 | 2022 | 170 | 1.780 |
Why?
|
| Respiration Disorders | 4 | 2022 | 39 | 1.540 |
Why?
|
| Neuronal Plasticity | 8 | 2018 | 187 | 1.400 |
Why?
|
| Neural Inhibition | 8 | 2018 | 97 | 1.360 |
Why?
|
| Respiratory Physiological Phenomena | 4 | 2014 | 48 | 1.250 |
Why?
|
| Sudden Infant Death | 2 | 2021 | 25 | 1.220 |
Why?
|
| Respiratory System | 8 | 2023 | 116 | 1.220 |
Why?
|
| Central Nervous System | 4 | 2018 | 151 | 1.160 |
Why?
|
| Larynx | 2 | 2023 | 38 | 1.120 |
Why?
|
| Motor Neurons | 5 | 2022 | 162 | 1.120 |
Why?
|
| Calcium | 6 | 2023 | 1151 | 1.110 |
Why?
|
| Neuroglia | 3 | 2023 | 104 | 1.110 |
Why?
|
| Animals, Newborn | 19 | 2021 | 510 | 1.040 |
Why?
|
| In Vitro Techniques | 23 | 2014 | 989 | 1.020 |
Why?
|
| Neocortex | 6 | 2012 | 95 | 1.020 |
Why?
|
| Optogenetics | 2 | 2022 | 30 | 1.010 |
Why?
|
| Interneurons | 4 | 2024 | 93 | 0.970 |
Why?
|
| Central Pattern Generators | 2 | 2021 | 4 | 0.960 |
Why?
|
| Autonomic Nervous System | 3 | 2023 | 56 | 0.960 |
Why?
|
| Neurodegenerative Diseases | 1 | 2023 | 43 | 0.890 |
Why?
|
| Mammals | 3 | 2018 | 227 | 0.880 |
Why?
|
| Morphine | 1 | 2023 | 130 | 0.870 |
Why?
|
| Neurotransmitter Agents | 3 | 2019 | 106 | 0.860 |
Why?
|
| Sneezing | 1 | 2022 | 36 | 0.840 |
Why?
|
| Deglutition | 1 | 2022 | 73 | 0.840 |
Why?
|
| Oxygen | 5 | 2018 | 726 | 0.820 |
Why?
|
| Receptors, Opioid, mu | 1 | 2021 | 45 | 0.810 |
Why?
|
| Brain | 6 | 2022 | 2214 | 0.790 |
Why?
|
| Mice, Transgenic | 11 | 2024 | 1540 | 0.780 |
Why?
|
| Hypoxia, Brain | 4 | 2018 | 41 | 0.760 |
Why?
|
| Artificial Intelligence | 1 | 2023 | 295 | 0.750 |
Why?
|
| Oxygen Consumption | 3 | 2010 | 239 | 0.750 |
Why?
|
| Neurophysiology | 1 | 2020 | 14 | 0.750 |
Why?
|
| Sodium Channels | 7 | 2012 | 129 | 0.730 |
Why?
|
| Editorial Policies | 1 | 2020 | 32 | 0.720 |
Why?
|
| Neural Pathways | 4 | 2016 | 308 | 0.720 |
Why?
|
| Substance P | 5 | 2019 | 61 | 0.690 |
Why?
|
| Opioid-Related Disorders | 1 | 2021 | 161 | 0.650 |
Why?
|
| Periodicals as Topic | 1 | 2020 | 167 | 0.630 |
Why?
|
| Calcium Channels | 4 | 2007 | 182 | 0.620 |
Why?
|
| Synapses | 5 | 2016 | 265 | 0.620 |
Why?
|
| Ion Channels | 4 | 2017 | 246 | 0.600 |
Why?
|
| Dentate Gyrus | 4 | 2021 | 32 | 0.570 |
Why?
|
| Carbon Dioxide | 1 | 2017 | 188 | 0.570 |
Why?
|
| Respiratory Burst | 3 | 2006 | 18 | 0.560 |
Why?
|
| Patch-Clamp Techniques | 13 | 2011 | 396 | 0.560 |
Why?
|
| Humans | 39 | 2024 | 86526 | 0.550 |
Why?
|
| Hippocampus | 2 | 2011 | 442 | 0.540 |
Why?
|
| Pulmonary Ventilation | 2 | 2013 | 32 | 0.530 |
Why?
|
| Dinoprostone | 2 | 2014 | 69 | 0.510 |
Why?
|
| Lip | 1 | 2014 | 16 | 0.500 |
Why?
|
| Sleep Apnea, Obstructive | 2 | 2018 | 219 | 0.500 |
Why?
|
| Organ Culture Techniques | 7 | 2021 | 135 | 0.490 |
Why?
|
| Seizures | 3 | 2022 | 295 | 0.490 |
Why?
|
| Substantia Nigra | 2 | 2023 | 27 | 0.460 |
Why?
|
| Calcium Channels, N-Type | 1 | 2013 | 17 | 0.450 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2013 | 36 | 0.450 |
Why?
|
| Norepinephrine | 3 | 2014 | 167 | 0.450 |
Why?
|
| Polysomnography | 3 | 2013 | 151 | 0.450 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2014 | 165 | 0.450 |
Why?
|
| Hyperthermia, Induced | 2 | 2004 | 72 | 0.430 |
Why?
|
| Sex Characteristics | 2 | 2020 | 319 | 0.420 |
Why?
|
| Neurogenesis | 4 | 2018 | 74 | 0.420 |
Why?
|
| Female | 31 | 2021 | 44489 | 0.410 |
Why?
|
| Pyramidal Cells | 4 | 2016 | 80 | 0.410 |
Why?
|
| Invertebrates | 1 | 2011 | 31 | 0.400 |
Why?
|
| Lung Diseases | 1 | 2013 | 263 | 0.400 |
Why?
|
| Adaptation, Physiological | 3 | 2008 | 306 | 0.400 |
Why?
|
| Oxidants | 1 | 2011 | 86 | 0.400 |
Why?
|
| Tetrodotoxin | 7 | 2012 | 50 | 0.390 |
Why?
|
| Infant, Premature | 1 | 2013 | 288 | 0.390 |
Why?
|
| Hydrogen Peroxide | 1 | 2011 | 158 | 0.390 |
Why?
|
| Vertebrates | 1 | 2011 | 90 | 0.390 |
Why?
|
| Disease Models, Animal | 6 | 2023 | 2232 | 0.380 |
Why?
|
| Male | 32 | 2023 | 40944 | 0.380 |
Why?
|
| Isoflurane | 2 | 2024 | 64 | 0.370 |
Why?
|
| Anesthetics, Inhalation | 2 | 2024 | 95 | 0.370 |
Why?
|
| Flufenamic Acid | 6 | 2014 | 13 | 0.360 |
Why?
|
| Excitatory Postsynaptic Potentials | 5 | 2018 | 87 | 0.350 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 4 | 2020 | 16 | 0.350 |
Why?
|
| Seals, Earless | 1 | 2008 | 1 | 0.340 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2008 | 27 | 0.340 |
Why?
|
| Behavior, Animal | 1 | 2011 | 373 | 0.330 |
Why?
|
| Riluzole | 5 | 2014 | 15 | 0.310 |
Why?
|
| Homeostasis | 3 | 2018 | 409 | 0.310 |
Why?
|
| Mice, Inbred C57BL | 12 | 2023 | 3092 | 0.310 |
Why?
|
| Epilepsy | 3 | 2022 | 395 | 0.300 |
Why?
|
| Wakefulness | 2 | 2012 | 134 | 0.300 |
Why?
|
| Biophysics | 3 | 2019 | 152 | 0.290 |
Why?
|
| Respiratory Rate | 3 | 2023 | 20 | 0.280 |
Why?
|
| Electric Stimulation | 5 | 2011 | 347 | 0.280 |
Why?
|
| Heart Rate | 3 | 2012 | 492 | 0.280 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 4 | 2012 | 87 | 0.270 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2006 | 52 | 0.270 |
Why?
|
| Birds | 1 | 2007 | 157 | 0.260 |
Why?
|
| Intellectual Disability | 2 | 2022 | 186 | 0.240 |
Why?
|
| Cadmium | 5 | 2014 | 28 | 0.240 |
Why?
|
| Evoked Potentials | 2 | 2013 | 190 | 0.240 |
Why?
|
| Oxazines | 1 | 2023 | 13 | 0.230 |
Why?
|
| Epinephrine | 1 | 2023 | 84 | 0.230 |
Why?
|
| Albuterol | 1 | 2023 | 35 | 0.230 |
Why?
|
| Exhalation | 1 | 2023 | 7 | 0.230 |
Why?
|
| Bronchodilator Agents | 1 | 2023 | 65 | 0.230 |
Why?
|
| Fentanyl | 1 | 2023 | 65 | 0.230 |
Why?
|
| Child | 8 | 2023 | 6921 | 0.230 |
Why?
|
| Excitatory Amino Acid Antagonists | 5 | 2011 | 78 | 0.230 |
Why?
|
| Receptors, Serotonin | 1 | 2002 | 34 | 0.220 |
Why?
|
| Astrocytes | 1 | 2023 | 139 | 0.220 |
Why?
|
| Tachykinins | 1 | 2002 | 12 | 0.220 |
Why?
|
| Circadian Rhythm | 2 | 2020 | 303 | 0.220 |
Why?
|
| Peripheral Nervous System | 1 | 2002 | 21 | 0.220 |
Why?
|
| Electrophysiology | 5 | 2008 | 401 | 0.220 |
Why?
|
| Fever | 1 | 2003 | 125 | 0.210 |
Why?
|
| Hypoglossal Nerve | 2 | 2013 | 26 | 0.210 |
Why?
|
| Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 1 | 2021 | 22 | 0.210 |
Why?
|
| Parkinson Disease | 1 | 2023 | 132 | 0.210 |
Why?
|
| Protein Precursors | 1 | 2002 | 143 | 0.210 |
Why?
|
| Homeodomain Proteins | 3 | 2022 | 535 | 0.210 |
Why?
|
| Sodium Channel Blockers | 5 | 2014 | 27 | 0.200 |
Why?
|
| Electron Transport Complex I | 3 | 2024 | 28 | 0.200 |
Why?
|
| Heat-Shock Response | 1 | 2002 | 46 | 0.200 |
Why?
|
| Drug Interactions | 4 | 2011 | 248 | 0.200 |
Why?
|
| Parkinsonian Disorders | 1 | 2021 | 21 | 0.200 |
Why?
|
| Deglutition Disorders | 1 | 2022 | 115 | 0.190 |
Why?
|
| Heat-Shock Proteins | 1 | 2002 | 179 | 0.190 |
Why?
|
| Dysautonomia, Familial | 2 | 2011 | 2 | 0.190 |
Why?
|
| Cytoskeletal Proteins | 1 | 2021 | 223 | 0.190 |
Why?
|
| Time Factors | 5 | 2016 | 5209 | 0.180 |
Why?
|
| Strychnine | 2 | 2018 | 7 | 0.180 |
Why?
|
| Potassium Channel Blockers | 2 | 2013 | 64 | 0.180 |
Why?
|
| Signal Transduction | 4 | 2023 | 3240 | 0.180 |
Why?
|
| Lung | 1 | 2005 | 1168 | 0.170 |
Why?
|
| Child, Preschool | 6 | 2020 | 3610 | 0.170 |
Why?
|
| Serotonin Antagonists | 3 | 2010 | 35 | 0.170 |
Why?
|
| Receptors, Adrenergic, alpha-1 | 2 | 2010 | 7 | 0.170 |
Why?
|
| Cluster Analysis | 3 | 2017 | 369 | 0.160 |
Why?
|
| Vagotomy | 1 | 2018 | 12 | 0.160 |
Why?
|
| Pyridazines | 1 | 2018 | 22 | 0.160 |
Why?
|
| Diving | 2 | 2008 | 5 | 0.160 |
Why?
|
| Cerebral Cortex | 3 | 2021 | 584 | 0.160 |
Why?
|
| Plethysmography | 2 | 2008 | 18 | 0.160 |
Why?
|
| Nonlinear Dynamics | 1 | 2018 | 73 | 0.160 |
Why?
|
| Feedback, Physiological | 1 | 2018 | 62 | 0.160 |
Why?
|
| Sleep | 1 | 2022 | 444 | 0.150 |
Why?
|
| Oxidative Stress | 1 | 2020 | 447 | 0.150 |
Why?
|
| Receptor, Serotonin, 5-HT2A | 3 | 2011 | 14 | 0.150 |
Why?
|
| Mice, Knockout | 5 | 2016 | 1923 | 0.150 |
Why?
|
| Peptides | 1 | 2021 | 639 | 0.150 |
Why?
|
| RNA | 1 | 2021 | 560 | 0.150 |
Why?
|
| Neural Stem Cells | 2 | 2018 | 58 | 0.150 |
Why?
|
| Cognition | 1 | 2022 | 570 | 0.150 |
Why?
|
| Cell Hypoxia | 2 | 2008 | 164 | 0.150 |
Why?
|
| Cholinergic Neurons | 1 | 2016 | 8 | 0.150 |
Why?
|
| Mice, Inbred Strains | 3 | 2012 | 307 | 0.140 |
Why?
|
| Mutation | 3 | 2013 | 3960 | 0.140 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2016 | 44 | 0.140 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2016 | 83 | 0.140 |
Why?
|
| Glutamine | 1 | 2016 | 76 | 0.140 |
Why?
|
| GABA Antagonists | 3 | 2011 | 25 | 0.140 |
Why?
|
| Cocaine | 1 | 2016 | 76 | 0.140 |
Why?
|
| Nucleus Accumbens | 1 | 2016 | 113 | 0.130 |
Why?
|
| Progesterone | 1 | 2015 | 110 | 0.130 |
Why?
|
| Neoplastic Stem Cells | 1 | 2017 | 143 | 0.130 |
Why?
|
| Transcription Factors | 2 | 2021 | 1559 | 0.130 |
Why?
|
| Encephalitis | 1 | 2015 | 104 | 0.130 |
Why?
|
| Cell Nucleus | 1 | 2017 | 579 | 0.130 |
Why?
|
| Potassium | 3 | 2004 | 281 | 0.130 |
Why?
|
| Glioblastoma | 1 | 2017 | 254 | 0.130 |
Why?
|
| Case-Control Studies | 3 | 2008 | 1803 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2016 | 1961 | 0.130 |
Why?
|
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 2 | 2011 | 14 | 0.120 |
Why?
|
| N-Methylaspartate | 2 | 2010 | 51 | 0.120 |
Why?
|
| Excitatory Amino Acid Agonists | 2 | 2010 | 45 | 0.120 |
Why?
|
| Sodium | 2 | 2006 | 341 | 0.120 |
Why?
|
| Membrane Potentials | 3 | 2005 | 435 | 0.120 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2013 | 72 | 0.120 |
Why?
|
| Phrenic Nerve | 1 | 2013 | 42 | 0.120 |
Why?
|
| Calcium Channels, Q-Type | 1 | 2013 | 8 | 0.120 |
Why?
|
| KATP Channels | 1 | 2013 | 19 | 0.120 |
Why?
|
| Calcium Channels, P-Type | 1 | 2013 | 10 | 0.110 |
Why?
|
| Stress, Psychological | 1 | 2016 | 313 | 0.110 |
Why?
|
| Ketanserin | 2 | 2010 | 10 | 0.110 |
Why?
|
| Mice, 129 Strain | 1 | 2013 | 55 | 0.110 |
Why?
|
| Sleep Apnea Syndromes | 2 | 2018 | 103 | 0.110 |
Why?
|
| Microglia | 2 | 2015 | 102 | 0.110 |
Why?
|
| Piperazines | 2 | 2011 | 272 | 0.110 |
Why?
|
| Mitochondria | 1 | 2016 | 535 | 0.110 |
Why?
|
| Leigh Disease | 1 | 2012 | 2 | 0.110 |
Why?
|
| Risk Factors | 2 | 2013 | 5413 | 0.110 |
Why?
|
| Integrases | 1 | 2012 | 59 | 0.110 |
Why?
|
| Picrotoxin | 1 | 2011 | 5 | 0.100 |
Why?
|
| Deferoxamine | 1 | 2011 | 18 | 0.100 |
Why?
|
| Ferrous Compounds | 1 | 2011 | 17 | 0.100 |
Why?
|
| Gap Junctions | 2 | 2017 | 142 | 0.100 |
Why?
|
| T-Box Domain Proteins | 1 | 2013 | 118 | 0.100 |
Why?
|
| Malondialdehyde | 1 | 2011 | 27 | 0.100 |
Why?
|
| Synaptic Potentials | 1 | 2011 | 15 | 0.100 |
Why?
|
| Siderophores | 1 | 2011 | 22 | 0.100 |
Why?
|
| Lipid Peroxidation | 1 | 2011 | 44 | 0.100 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 1197 | 0.100 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 1 | 2011 | 9 | 0.100 |
Why?
|
| Transient Receptor Potential Channels | 1 | 2011 | 4 | 0.100 |
Why?
|
| Phenanthrenes | 1 | 2011 | 2 | 0.100 |
Why?
|
| TRPM Cation Channels | 1 | 2011 | 7 | 0.100 |
Why?
|
| Egtazic Acid | 1 | 2011 | 34 | 0.100 |
Why?
|
| Cardiovascular System | 1 | 2011 | 71 | 0.100 |
Why?
|
| Piperidines | 2 | 2010 | 181 | 0.100 |
Why?
|
| Brain Neoplasms | 1 | 2017 | 763 | 0.100 |
Why?
|
| Motor Activity | 2 | 2016 | 327 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 2269 | 0.100 |
Why?
|
| Light | 1 | 2012 | 289 | 0.100 |
Why?
|
| Chelating Agents | 1 | 2011 | 69 | 0.100 |
Why?
|
| Locus Coeruleus | 1 | 2010 | 3 | 0.100 |
Why?
|
| Serotonin 5-HT2 Receptor Antagonists | 1 | 2010 | 7 | 0.100 |
Why?
|
| Isoindoles | 1 | 2010 | 14 | 0.100 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 2010 | 14 | 0.090 |
Why?
|
| Adrenergic alpha-1 Receptor Antagonists | 1 | 2010 | 8 | 0.090 |
Why?
|
| Receptors, Serotonin, 5-HT2 | 1 | 2010 | 15 | 0.090 |
Why?
|
| Anesthetics, Local | 2 | 2010 | 76 | 0.090 |
Why?
|
| Microinjections | 1 | 2010 | 70 | 0.090 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2013 | 623 | 0.090 |
Why?
|
| Neurokinin-1 Receptor Antagonists | 1 | 2010 | 34 | 0.090 |
Why?
|
| Raphe Nuclei | 1 | 2010 | 37 | 0.090 |
Why?
|
| Calcium Channel Blockers | 2 | 2014 | 203 | 0.090 |
Why?
|
| Electromyography | 1 | 2010 | 183 | 0.090 |
Why?
|
| Mutation, Missense | 2 | 2022 | 276 | 0.090 |
Why?
|
| Acetylcholine | 1 | 2009 | 176 | 0.090 |
Why?
|
| Prosencephalon | 1 | 2009 | 62 | 0.090 |
Why?
|
| Dopamine | 1 | 2011 | 275 | 0.090 |
Why?
|
| Data Interpretation, Statistical | 2 | 2012 | 297 | 0.090 |
Why?
|
| Finches | 1 | 2009 | 55 | 0.090 |
Why?
|
| Biological Evolution | 1 | 2016 | 918 | 0.080 |
Why?
|
| Vocalization, Animal | 1 | 2009 | 100 | 0.080 |
Why?
|
| Regional Blood Flow | 1 | 2008 | 197 | 0.080 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2011 | 339 | 0.080 |
Why?
|
| Aging | 1 | 2013 | 690 | 0.080 |
Why?
|
| Presenilin-1 | 1 | 2008 | 100 | 0.080 |
Why?
|
| Cerebrovascular Circulation | 1 | 2008 | 212 | 0.080 |
Why?
|
| Hibernation | 1 | 2007 | 5 | 0.080 |
Why?
|
| Cell Survival | 2 | 2017 | 969 | 0.070 |
Why?
|
| Species Specificity | 1 | 2008 | 678 | 0.070 |
Why?
|
| Cell Membrane | 3 | 2004 | 666 | 0.070 |
Why?
|
| Cells, Cultured | 3 | 2014 | 2818 | 0.070 |
Why?
|
| Infant | 1 | 2013 | 3040 | 0.070 |
Why?
|
| Death, Sudden | 1 | 2006 | 40 | 0.070 |
Why?
|
| Respiratory System Abnormalities | 1 | 2005 | 6 | 0.070 |
Why?
|
| Stem Cells | 1 | 2008 | 351 | 0.070 |
Why?
|
| Visual Cortex | 1 | 2008 | 251 | 0.070 |
Why?
|
| Cadmium Chloride | 1 | 2005 | 12 | 0.070 |
Why?
|
| Nifedipine | 1 | 2005 | 28 | 0.070 |
Why?
|
| Tetraethylammonium | 1 | 2005 | 24 | 0.070 |
Why?
|
| Age Factors | 2 | 2013 | 1849 | 0.070 |
Why?
|
| Environment | 1 | 2007 | 219 | 0.060 |
Why?
|
| Cell Proliferation | 3 | 2018 | 1578 | 0.060 |
Why?
|
| Alzheimer Disease | 1 | 2008 | 470 | 0.060 |
Why?
|
| Analysis of Variance | 3 | 2013 | 912 | 0.060 |
Why?
|
| Cholinergic Agents | 1 | 2024 | 17 | 0.060 |
Why?
|
| Decerebrate State | 1 | 2003 | 4 | 0.060 |
Why?
|
| Animal Experimentation | 1 | 2003 | 7 | 0.060 |
Why?
|
| Electrocardiography | 1 | 2006 | 478 | 0.060 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 2003 | 17 | 0.060 |
Why?
|
| Dopaminergic Neurons | 1 | 2023 | 25 | 0.060 |
Why?
|
| Serotonin Receptor Agonists | 1 | 2002 | 15 | 0.060 |
Why?
|
| Electric Conductivity | 1 | 2002 | 144 | 0.060 |
Why?
|
| Spinal Cord | 1 | 2024 | 243 | 0.050 |
Why?
|
| KCNQ Potassium Channels | 1 | 2022 | 7 | 0.050 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2002 | 78 | 0.050 |
Why?
|
| Cricetulus | 1 | 2022 | 126 | 0.050 |
Why?
|
| HSC70 Heat-Shock Proteins | 1 | 2002 | 5 | 0.050 |
Why?
|
| HSP72 Heat-Shock Proteins | 1 | 2002 | 23 | 0.050 |
Why?
|
| Mice, Mutant Strains | 1 | 2002 | 229 | 0.050 |
Why?
|
| Computer Simulation | 1 | 2006 | 1078 | 0.050 |
Why?
|
| Potassium Channels | 1 | 2024 | 340 | 0.050 |
Why?
|
| Protein Kinase C | 1 | 2002 | 270 | 0.050 |
Why?
|
| Temperature | 1 | 2003 | 396 | 0.050 |
Why?
|
| Models, Biological | 1 | 2008 | 1749 | 0.050 |
Why?
|
| Cricetinae | 1 | 2022 | 560 | 0.050 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2002 | 113 | 0.050 |
Why?
|
| Respiration, Artificial | 1 | 2003 | 334 | 0.050 |
Why?
|
| Reference Values | 1 | 2002 | 674 | 0.050 |
Why?
|
| Recovery of Function | 1 | 2002 | 272 | 0.050 |
Why?
|
| Gene Deletion | 1 | 2021 | 329 | 0.050 |
Why?
|
| HEK293 Cells | 1 | 2022 | 615 | 0.050 |
Why?
|
| Monitoring, Ambulatory | 2 | 2011 | 32 | 0.050 |
Why?
|
| Kinetics | 1 | 2002 | 1513 | 0.050 |
Why?
|
| Stress, Physiological | 1 | 2002 | 226 | 0.050 |
Why?
|
| Genes, X-Linked | 1 | 2020 | 37 | 0.050 |
Why?
|
| Bicuculline | 2 | 2010 | 18 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2002 | 1014 | 0.040 |
Why?
|
| Exons | 1 | 2021 | 450 | 0.040 |
Why?
|
| Reactive Nitrogen Species | 1 | 2018 | 8 | 0.040 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2018 | 21 | 0.040 |
Why?
|
| Free Radical Scavengers | 1 | 2018 | 59 | 0.040 |
Why?
|
| Long-Term Potentiation | 1 | 2018 | 47 | 0.040 |
Why?
|
| Neuropeptides | 1 | 2018 | 112 | 0.040 |
Why?
|
| GABA-A Receptor Antagonists | 2 | 2010 | 15 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2018 | 176 | 0.040 |
Why?
|
| Adolescent | 4 | 2011 | 8976 | 0.040 |
Why?
|
| Cell Lineage | 1 | 2018 | 273 | 0.040 |
Why?
|
| Electroencephalography | 1 | 2021 | 707 | 0.040 |
Why?
|
| Miniature Postsynaptic Potentials | 1 | 2016 | 6 | 0.040 |
Why?
|
| Tissue Culture Techniques | 1 | 2016 | 79 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 236 | 0.040 |
Why?
|
| Glycine Agents | 2 | 2008 | 5 | 0.030 |
Why?
|
| Acoustic Stimulation | 1 | 2016 | 130 | 0.030 |
Why?
|
| Cell Differentiation | 2 | 2013 | 1458 | 0.030 |
Why?
|
| Bradykinin | 1 | 2014 | 46 | 0.030 |
Why?
|
| Receptors, Glutamate | 1 | 2014 | 24 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2015 | 285 | 0.030 |
Why?
|
| Ganglia, Spinal | 1 | 2014 | 72 | 0.030 |
Why?
|
| Photic Stimulation | 1 | 2016 | 493 | 0.030 |
Why?
|
| Receptors, Cholinergic | 1 | 2014 | 76 | 0.030 |
Why?
|
| Histamine | 1 | 2014 | 126 | 0.030 |
Why?
|
| Nestin | 1 | 2013 | 18 | 0.030 |
Why?
|
| Bromodeoxyuridine | 1 | 2013 | 57 | 0.030 |
Why?
|
| Intermediate Filament Proteins | 1 | 2013 | 35 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2017 | 1537 | 0.030 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2013 | 66 | 0.030 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2013 | 34 | 0.030 |
Why?
|
| Stem Cell Niche | 1 | 2013 | 21 | 0.030 |
Why?
|
| Receptors, CXCR4 | 1 | 2013 | 44 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 1920 | 0.030 |
Why?
|
| Plethysmography, Whole Body | 1 | 2012 | 9 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2013 | 207 | 0.030 |
Why?
|
| Dependovirus | 1 | 2012 | 33 | 0.030 |
Why?
|
| Microscopy, Video | 1 | 2012 | 34 | 0.030 |
Why?
|
| Gliosis | 1 | 2012 | 35 | 0.030 |
Why?
|
| Halorhodopsins | 1 | 2012 | 5 | 0.030 |
Why?
|
| Transcriptome | 1 | 2017 | 580 | 0.030 |
Why?
|
| Vestibular Nuclei | 1 | 2012 | 28 | 0.030 |
Why?
|
| Mice, Inbred ICR | 1 | 2012 | 70 | 0.030 |
Why?
|
| Channelrhodopsins | 1 | 2012 | 7 | 0.030 |
Why?
|
| GATA3 Transcription Factor | 1 | 2012 | 48 | 0.030 |
Why?
|
| Archaeal Proteins | 1 | 2012 | 18 | 0.030 |
Why?
|
| Optics and Photonics | 1 | 2012 | 27 | 0.030 |
Why?
|
| Apnea | 1 | 2012 | 29 | 0.030 |
Why?
|
| Electroporation | 1 | 2012 | 55 | 0.030 |
Why?
|
| Electrophysiological Phenomena | 1 | 2012 | 49 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2013 | 305 | 0.030 |
Why?
|
| Rhombencephalon | 1 | 2012 | 50 | 0.030 |
Why?
|
| Tamoxifen | 1 | 2013 | 168 | 0.030 |
Why?
|
| Cell Count | 1 | 2012 | 195 | 0.030 |
Why?
|
| Vagus Nerve | 1 | 2011 | 45 | 0.030 |
Why?
|
| RNA, Untranslated | 1 | 2012 | 63 | 0.030 |
Why?
|
| Magnesium | 1 | 2012 | 177 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 2012 | 307 | 0.030 |
Why?
|
| Adrenergic alpha-2 Receptor Antagonists | 1 | 2011 | 4 | 0.030 |
Why?
|
| Serotonin 5-HT2 Receptor Agonists | 1 | 2011 | 4 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2012 | 144 | 0.030 |
Why?
|
| Animals, Outbred Strains | 1 | 2011 | 15 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2012 | 268 | 0.030 |
Why?
|
| Sympathetic Nervous System | 1 | 2011 | 104 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2013 | 384 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 1384 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 2426 | 0.020 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2010 | 39 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2013 | 279 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2012 | 439 | 0.020 |
Why?
|
| Genetic Therapy | 1 | 2012 | 342 | 0.020 |
Why?
|
| Cholinergic Fibers | 1 | 2009 | 23 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 579 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 503 | 0.020 |
Why?
|
| Neurochemistry | 1 | 2009 | 2 | 0.020 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2009 | 27 | 0.020 |
Why?
|
| Prognosis | 1 | 2017 | 3673 | 0.020 |
Why?
|
| Oxotremorine | 1 | 2008 | 4 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2008 | 94 | 0.020 |
Why?
|
| Muscarinic Agonists | 1 | 2008 | 23 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2008 | 370 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2008 | 270 | 0.020 |
Why?
|
| Social Environment | 1 | 2008 | 188 | 0.020 |
Why?
|
| Proteins | 1 | 2012 | 777 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 2357 | 0.020 |
Why?
|
| Heart | 1 | 2008 | 539 | 0.020 |
Why?
|
| Lanthanum | 1 | 2004 | 16 | 0.020 |
Why?
|
| Receptors, GABA-A | 1 | 2004 | 32 | 0.020 |
Why?
|
| Receptors, Glycine | 1 | 2004 | 10 | 0.020 |
Why?
|
| Cytokines | 1 | 2008 | 776 | 0.020 |
Why?
|
| Disease Progression | 1 | 2009 | 1531 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2017 | 7981 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2002 | 271 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2008 | 2765 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 3350 | 0.010 |
Why?
|